Moderna to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Rhea-AI Summary

Moderna (NASDAQ:MRNA) announced that President Stephen Hoge, M.D., will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 10:00 a.m. ET. A live webcast will be available on the Investors section of Moderna's website, with a replay accessible for at least 30 days afterward. Over the past decade, Moderna has evolved into a leader in mRNA therapeutics, having developed vaccines for various diseases, including COVID-19.

CAMBRIDGE, MA / ACCESSWIRE / September 6, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Stephen Hoge, M.D., President, will participate in a fireside chat at the Morgan Stanley 20^th Annual Global Healthcare Conference on Tuesday, September 13^th at 10:00 a.m. ET.

A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com. A replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.

About Moderna

In 10 years since its inception, Moderna has transformed from a research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators. Most recently, Moderna's capabilities have come together to allow the authorized use and approval of one of the earliest and most effective vaccines against the COVID-19 pandemic.

Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past seven years. To learn more, visit www.modernatx.com.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View source version on accesswire.com:
https://www.accesswire.com/714793/Moderna-to-Present-at-the-Morgan-Stanley-20th-Annual-Global-Healthcare-Conference

FAQ

When will Moderna participate in the Morgan Stanley 20th Annual Global Healthcare Conference?

Moderna will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 10:00 a.m. ET.

Who from Moderna will be speaking at the conference?

President Stephen Hoge, M.D., will represent Moderna at the conference.

Where can I watch the Moderna conference presentation live?

You can watch the live webcast of the presentation in the 'Events and Presentations' section of Moderna's Investors website.

How long will the Moderna conference replay be available?

The replay of Moderna’s presentation will be archived on their website for at least 30 days following the event.

What has Moderna accomplished in the past decade?

In the past decade, Moderna has developed a diverse portfolio of mRNA therapeutics and vaccines, including one of the most effective COVID-19 vaccines.